Consensus Cartesian Therapeutics, Inc.

Equities

RNAC

US8162121045

Delayed Nasdaq 01:39:03 2024-03-28 pm EDT 5-day change 1st Jan Change
0.6671 USD +1.01% Intraday chart for Cartesian Therapeutics, Inc. -5.21% -3.23%

Evolution of the average Target Price on Cartesian Therapeutics, Inc.

Price target over the last 5 years

History of analyst recommendation changes

45038.hJckzPv7AwCYAGysREx1m5GA8pkic5IBqdRC8XQG3v8.tKMJ-o-Ia1_1aC3jcBkxq9vHucFJR8d4-4USrjtynIbL_xaEk8lCRa43Cw~1ddb1407c94e36734cea4df637eb31c6

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.6604 USD
Average target price
2 USD
Spread / Average Target
+202.85%
High Price Target
2 USD
Spread / Highest target
+202.85%
Low Price Target
2 USD
Spread / Lowest Target
+202.85%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Cartesian Therapeutics, Inc.

Mizuho Securities
Needham & Co.
HC Wainwright
Canaccord Genuity
SVB Securities LLC
BTIG
William Blair & Co.
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings